If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares

6 Jul 2026 07:00

RNS Number : 0522L
3i Group PLC
06 July 2026
 

6 July 2026

3i GROUP PLC

 

TRANSACTIONS IN OWN SHARES

 

 

 

3i Group plc (the "Company" or "3i") announces today that it has purchased for cancellation the following number of its ordinary shares of 73 19/22p each ("Shares") through Barclays Capital Securities Limited as part of the £750 million share buyback programme announced by 3i on 14 May 2026 (the "Programme"):

 

Date of transactions

Trading Venues

Aggregated volume (Shares)

Lowest Price per Share (£)

Highest Price per Share (£)

Volume weighted average price paid per share (£)

29/06/2026

London Stock Exchange

230,858

24.8400

25.4300

25.1334

30/06/2026

London Stock Exchange

273,998

24.6100

25.1800

24.9235

01/07/2026

London Stock Exchange

230,858

24.8300

25.2100

25.0282

02/07/2026

London Stock Exchange

230,858

25.0000

25.9900

25.4465

03/07/2026

London Stock Exchange

221,610

25.6400

26.1200

25.8969

 

 

Following the above purchase and cancellation of the Shares, the total number of voting rights in 3i will be 1,012,193,551 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 3i does not hold any shares in treasury.

 

Since the commencement of this Programme, 3i has purchased 12,518,412 Shares for cancellation at an aggregate cost of £283,619,531.40 (excluding fees and taxes).

 

In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018, a full breakdown of the individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the Programme is detailed below.

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

http://www.rns-pdf.londonstockexchange.com/rns/0522L_1-2026-7-3.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSZZGGNNFLGVZM

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS